Agmatine Mediated Arrest of Proliferation
Agmatine Mediated Arrest of Proliferation
批准号:
6516797
负责人:
JOSEPH SATRIANO
金额:
$9.29万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2004-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant)
Polyamines (PA) are small cationic molecules required for entry and progression
through the cell cycle. To address their increased need for PA, cells with
short cycling times up-regulate both PA biosynthesis and PA transport. PA
autoregulate when high intracellular PA concentrations induce a full-length
active protein, antizyme (Az), via a translational +1 frameshift. Az inhibits
both the first and rate-limiting enzyme of PA biosynthesis, ornithine
decarboxylase (ODC), and PA transport. This 2 pronged mechanism effectively
limits the ability of the cell to acquire PA.
The kidney is exceptional in demonstrating high intracellular agmatine (Agm)
levels (-400 uM) and high constitutive activity of the enzyme that converts
arginine to Agm, arginine decarboxylase (ADC). The kidney appears an important
source of systemic Agm. We have recently shown that Agm can induce Az. Agm
induction of Az depletes intracellular PA levels in transformed cell lines and
markedly inhibits their proliferation. Agm is the only known molecule,
exclusive of the canonical PA, with the capacity to induce Az.
Further investigation of this kidney derived anti-proliferative molecule is
warranted. This proposal demonstrates Agm uptake is via PA transporters. These
transporters are undetectable in quiescent cells, and up regulated in rapidly
proliferating cells. We hypothesize that Agm selectively targets rapidly
proliferating cells. In SA #1 we characterize Agm transport and its dependence
on PA transporters. In SA#2 we evaluate targeting via the relative uptake vs.
effects of Agm in cell lines representing increasing stages of tumorigenesis.
In SA #3 we address the mechanisms of Agm mediated inhibition of proliferation.
We hypothesize that this active cell mediated mechanism may be analogous to
that noted for senescence.
Attaining a K01 award would allow the PI to formally establish his independence
for future R01 applications, and to pursue an appointment in the Academic
Research series at the University of California San Diego. UCSD has established
itself as a leading academic institution and thus provides an excellent
environment for the exchange of ideas and techniques essential for the growth
of the PI's career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Diabetic Kidney Growth/ Hypertrophy
-
批准号:7229955
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2006
-
负责人:JOSEPH SATRIANO
-
依托单位:
Modulation of Diabetic Kidney Growth/Hypertrophy
-
批准号:7031956
-
项目类别:
-
资助金额:$13.86万
-
财政年份:2006
-
负责人:JOSEPH SATRIANO
-
依托单位:
Tool to Define the Antiproliferative Effects of Agmatine
-
批准号:6976882
-
项目类别:
-
资助金额:$14.44万
-
财政年份:2005
-
负责人:JOSEPH SATRIANO
-
依托单位:
Tool to Define the Antiproliferative Effects of Agmatine
-
批准号:7140508
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2005
-
负责人:JOSEPH SATRIANO
-
依托单位:
Agmatine Mediated Arrest of Proliferation
-
批准号:6612544
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2001
-
负责人:JOSEPH SATRIANO
-
依托单位:
Agmatine Mediated Arrest of Proliferation
-
批准号:6383972
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2001
-
负责人:JOSEPH SATRIANO
-
依托单位:
海外基金